Cargando…

Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile

Warfarin-related nephropathy (WRN) is a renal complication of warfarin treatment associated with over-anticoagulation. We describe a case of a 73-year-old man affected by chronic kidney disease, essential hypertension and atrial fibrillation treated with warfarin. The patient presented a rapid cours...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Maso, Vittorio, Carraro, Michele, Bevilacqua, Elena, Bucconi, Sergio, Artero, Mary Louise, Boscutti, Giuliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Contributions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389147/ https://www.ncbi.nlm.nih.gov/pubmed/25859382 http://dx.doi.org/10.1093/ckj/sfu112

Ejemplares similares

Systematic Review of Pharmacogenetic Warfarin Dosing
por: van Schie, Rianne M. F., et al.
Publicado: (2009)

Warfarin-related Nephropathy
por: Golla, Anvesh, et al.
Publicado: (2018)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort
por: Al Ammari, Maha, et al.
Publicado: (2020)

Warfarin pharmacogenetics: How close are we to clinical practice?
por: Gaikwad, Tejasvita, et al.
Publicado: (2013)

Warfarin Dosage Response Related Pharmacogenetics in Chinese Population
por: Li, Siyue, et al.
Publicado: (2015)

Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database
por: Liu, Rong, et al.
Publicado: (2015)

Warfarin Anticoagulant Therapy: A Southern Italy Pharmacogenetics-Based Dosing Model
por: Mazzaccara, Cristina, et al.
Publicado: (2013)

Profiling of warfarin pharmacokinetics‐associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics‐dosing algorithm
por: Ndadza, Arinao, et al.
Publicado: (2021)

Delayed Intracranial Hemorrhage in Patients Taking Warfarin with Head Trauma
por: Macedo, Mark, et al.
Publicado: (2017)

Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients
por: Galvez, Jubby Marcela, et al.
Publicado: (2018)

Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin
por: Alberts, Mark, et al.
Publicado: (2020)

Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin
por: Kangelaris, Kirsten Neudoerffer, et al.
Publicado: (2009)

Establishment of a Han Chinese-specific pharmacogenetic-guided warfarin dosing algorithm
por: Pei, Lin, et al.
Publicado: (2018)

Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina
por: Ašić, Adna, et al.
Publicado: (2019)

A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation
por: Pengo, Vittorio, et al.
Publicado: (2015)

Influence of Sampling on the Determination of Warfarin and Warfarin Alcohols in Oral Fluid
por: Lomonaco, Tommaso, et al.
Publicado: (2014)

The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study
por: Gemmati, Donato, et al.
Publicado: (2016)

Small Molecule Membrane Transporters in the Mammalian Podocyte: A Pathogenic and Therapeutic Target
por: Zennaro, Cristina, et al.
Publicado: (2014)

A Pharmacogenetics-Based Warfarin Maintenance Dosing Algorithm from Northern Chinese Patients
por: Chen, Jinxing, et al.
Publicado: (2014)

A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics
por: Duconge, Jorge, et al.
Publicado: (2016)

Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds
por: Chang, Grace Shu-wen, et al.
Publicado: (2020)

Pharmacogenetic-Guided Algorithm to Improve Daily Dose of Warfarin in Elder Han-Chinese Population
por: Ren, Yirong, et al.
Publicado: (2020)

Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
por: Roche-Lima, Abiel, et al.
Publicado: (2020)

Warfarin related nephropathy: a case report and review of the literature
por: Ng, Chee Yong, et al.
Publicado: (2016)

Warfarin-related nephropathy in a patient with renal pelvic cancer
por: Nagasako, Yuki, et al.
Publicado: (2017)

Warfarin-Related Nephropathy Manifested as Diffuse Mesangial Proliferative Glomerulonephritis
por: Acquah, Frederick, et al.
Publicado: (2022)

Pharmacogenetics of warfarin in a paediatric population: Time in therapeutic range, initial and stable dosing, and adverse effects
por: Hawcutt, Daniel B, et al.
Publicado: (2014)

Warfarin overactivity
por: Yamanel, L, et al.
Publicado: (2005)

Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
por: Molteni, Mauro, et al.
Publicado: (2014)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
por: Nielsen, Peter Brønnum, et al.
Publicado: (2019)

Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores)
por: Branco, Claudia C, et al.
Publicado: (2009)

Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithms
por: Hamberg, Anna-Karin, et al.
Publicado: (2013)

Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials
por: Shi, Changcheng, et al.
Publicado: (2015)

Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin
por: Moeckel, Gilbert W., et al.
Publicado: (2013)

VKORC1 Pharmacogenetics and Pharmacoproteomics in Patients on Warfarin Anticoagulant Therapy: Transthyretin Precursor as a Potential Biomarker
por: Saminathan, Ramasamy, et al.
Publicado: (2010)

Erratum to: Warfarin dose prediction in children using pharmacometric bridging – comparison with published pharmacogenetic dosing algorithms
por: Hamberg, Anna-Karin, et al.
Publicado: (2013)

Moxifloxacin-warfarin interaction
por: Ji, Yan, et al.
Publicado: (2012)

An unusual case report on the possible role of Warfarin in migraine prophylaxis
por: Russo, Angelo, et al.
Publicado: (2013)

Warfarin and phenytoin drug interaction with possible purple glove syndrome
por: Hunter, Carolyn S., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6qd0rbnbpng745v972rlvpf3cb